Department of Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Diabetes. 2010 Nov;59(11):2708-14. doi: 10.2337/db10-1118.
Martin G. Myers Jr., MD, PhD, received the American Diabetes Association's prestigious 2010 Outstanding Scientific Achievement Award at the Association's 70th Scientific Sessions in Orlando, Florida, on 28 June 2010. The Outstanding Scientific Achievement Award recognizes outstanding scientific achievement in the field of diabetes, taking into consideration independence of thought and originality. Currently the Marilyn H. Vincent Professor of Diabetes Research at the University of Michigan, Ann Arbor, and Associate Professor in internal medicine and in molecular and integrative physiology at the University of Michigan Medical School, Dr. Myers began his impressive track record in diabetes research as a graduate student in the laboratory of Dr. Morris White at the Joslin Diabetes Center/Harvard Medical School. There, Dr. Myers deciphered many of the insulin signaling pathways engaged by insulin receptor substrate proteins. Following his graduation from the Harvard MD-PhD Program in 1997, Dr. Myers was promoted to instructor in medicine at the Joslin Diabetes Center/Harvard Medical School. He began his independent work by building a molecular framework for understanding the mechanisms of leptin signaling, including how individual phosphorylation sites on the leptin receptor recruit distinct signaling molecules. He was promoted to assistant professor at Harvard in 1999. In 2004, Dr. Myers moved to the University of Michigan, where he built upon the molecular framework of leptin signaling to probe the regulation of metabolism by individual leptin signals. Dr. Myers' laboratory revealed the specificity of leptin signals in metabolic control, including the role for leptin-STAT3 signaling in the regulation of energy balance and glucose homeostasis. His group also defined roles for leptin receptor feedback inhibition and hypothalamic mTor signaling in metabolism. Dr. Myers' laboratory has recently developed novel molecular approaches to elucidate the leptin-regulated brain circuits that contribute to metabolic control, enabling the discovery of novel brain systems and their functions. In 1998, Dr. Myers received the American Diabetes Association's Career Development Award for his scientific abilities. Dr. Myers' current support includes the National Institute of Diabetes and Digestive and Kidney Diseases MERIT Award.
马丁 G. 迈尔斯博士,医学博士,哲学博士,于 2010 年 6 月 28 日在佛罗里达州奥兰多举行的美国糖尿病协会第 70 届科学会议上获得该协会享有盛誉的 2010 年杰出科学成就奖。杰出科学成就奖表彰在糖尿病领域的杰出科学成就,同时考虑思想的独立性和创新性。目前,他是密歇根大学安阿伯分校的糖尿病研究玛丽莲 H. 文森特教授,以及密歇根大学医学院内科和分子与综合生理学副教授,迈尔斯博士从在哈佛医学院乔斯林糖尿病中心/哈佛医学院的莫里斯·怀特博士的实验室开始他令人印象深刻的糖尿病研究记录。在那里,迈尔斯博士破译了许多胰岛素受体底物蛋白参与的胰岛素信号通路。1997 年从哈佛 MD-PhD 项目毕业后,迈尔斯博士被提升为乔斯林糖尿病中心/哈佛医学院的内科讲师。他通过建立一个理解瘦素信号机制的分子框架开始了他的独立工作,包括瘦素受体上的个别磷酸化位点如何招募不同的信号分子。1999 年,他被提升为哈佛助理教授。2004 年,迈尔斯博士搬到密歇根大学,在那里他在瘦素信号的分子框架的基础上,探索单个瘦素信号对代谢的调节。迈尔斯博士的实验室揭示了瘦素信号在代谢控制中的特异性,包括瘦素-STAT3 信号在调节能量平衡和葡萄糖稳态中的作用。他的研究小组还定义了瘦素受体反馈抑制和下丘脑 mTor 信号在代谢中的作用。迈尔斯博士的实验室最近开发了新的分子方法来阐明参与代谢控制的瘦素调节的大脑回路,从而发现了新的大脑系统及其功能。1998 年,迈尔斯博士因其出色的科学能力获得了美国糖尿病协会的职业发展奖。迈尔斯博士目前的研究经费包括美国国立卫生研究院糖尿病、消化和肾脏疾病 MERIT 奖。